COVID-19 reinfection: Linked Possibilities and future outlook
- PMID: 33532377
- PMCID: PMC7842419
- DOI: 10.4103/jfmpc.jfmpc_1672_20
COVID-19 reinfection: Linked Possibilities and future outlook
Abstract
SARS-CoV-2 is the third major coronavirus epidemic to affect humans. There had been multiple instances of patients turning positive after recovering from SARS-2-CoV infection. Though many different theories emerge, false positive RT-PCR is logically the foremost cause and there is a general consensus that during quarantine re-infection from outside seems unlikely when strictly adhered to. As many new strains emerge worldwide during the course of on-going pandemic, the chances of re-infection cannot be ignored as it may contribute to false negative RT-PCR test results. SARS-2-CoV though a novel virus, is phylogenetically similar to SARS-like CoV with around 79% similarity. Studies on immunological response to these infections suggest that antibodies formed after infection confers immunity only for a short period of time before it starts to wane. Also studies on SARS-CoV-2 suggest that antibody formation and longevity of immunity in an individual is dependent on the strain of coronavirus, its severity and age of the person infected. All these considerations demand reviewing the treatment duration, discharge criteria, appropriate use of imaging techniques and importance of risk communication and health education to those recovered.
Keywords: Antibody; Covid; SARS; immunity; pandemic; radiological investigation; re-infection.
Copyright: © 2020 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.AIDS Rev. 2021 Jun 3;23(3):153-163. doi: 10.24875/AIDSRev.21000023. AIDS Rev. 2021. PMID: 34082440 Review.
-
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.Microbiol Spectr. 2021 Oct 31;9(2):e0008721. doi: 10.1128/Spectrum.00087-21. Epub 2021 Sep 1. Microbiol Spectr. 2021. PMID: 34468184 Free PMC article.
-
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951. doi: 10.1093/cid/ciaa1275. Clin Infect Dis. 2021. PMID: 32840608 Free PMC article.
-
Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.Clin Infect Dis. 2021 Dec 16;73(12):2217-2225. doi: 10.1093/cid/ciab148. Clin Infect Dis. 2021. PMID: 33598716 Free PMC article.
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
Cited by
-
Viral genome sequencing for Defining Re-infection with COVID-19.J Family Med Prim Care. 2021 Mar;10(3):1499-1500. doi: 10.4103/jfmpc.jfmpc_2410_20. Epub 2021 Apr 8. J Family Med Prim Care. 2021. PMID: 34041202 Free PMC article. No abstract available.
-
Distinguishing repeated polymerase chain reaction positivity from re-infections in COVID-19.Influenza Other Respir Viruses. 2021 Nov;15(6):742-749. doi: 10.1111/irv.12883. Epub 2021 Jul 23. Influenza Other Respir Viruses. 2021. PMID: 34296828 Free PMC article.
-
COVID-19 Reinfection in the Face of a Detectable Antibody Titer.Cureus. 2021 Mar 22;13(3):e14033. doi: 10.7759/cureus.14033. Cureus. 2021. PMID: 33767941 Free PMC article.
-
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001. Int J Environ Res Public Health. 2021. PMID: 34682746 Free PMC article.
-
Predictive determinants of overall survival among re-infected COVID-19 patients using the elastic-net regularized Cox proportional hazards model: a machine-learning algorithm.BMC Public Health. 2022 Jan 5;22(1):10. doi: 10.1186/s12889-021-12383-3. BMC Public Health. 2022. PMID: 34986818 Free PMC article.
References
-
- Morens DM, Daszak P, Taubenberger JK. Escaping Pandora's box — Another novel coronavirus. N Engl J Med. 2020;382:1293–5. - PubMed
-
- Questions raised over COVID-19 reinfection after Japanese woman develops illness again | The Japan Times. cited 2020 Jul 10. Available from: https://www.japantimes.co.jp/news/2020/02/28/national/coronavirus-reinfe...
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous